Skip to main content
Medical Reference · Condition Monograph

Chronic Urticaria

만성담마진

Chronic urticaria (chronic hives, CU) is a condition in which a person experiences, over a long period, a state in which "hives" repeatedly appear on the skin and then disappear.

History

Chronic urticaria (chronic hives, CU) is a condition in which a person experiences, over a long period, a state in which "hives" repeatedly appear on the skin and then disappear. Because hives themselves are a symptom commonly experienced in everyday life, in the past they tended to be understood mainly as one form of "allergic reaction" to things such as foods, drugs, or insect bites. Over time, however, it gradually became clear that hives are not caused only by external allergens, and that they can also occur when inflammatory and immune responses within the body switch on by themselves.

In medical history, the name for hives is known to derive from the way the skin swells up "as when stung by nettles." In fact, the appearance of skin suddenly turning red, swelling, and itching has been recorded since very long ago. However, because skin diseases could not be subdivided and classified in the past as they are now, it took time before acute urticaria, which passes quickly, and chronic urticaria, which recurs over a long period, came to be described separately.

In modern times, as "hives recurring for 6 weeks or more" came to be defined as chronic, chronic urticaria became a more clearly defined clinical category. In particular, because the cause is often difficult to find, it greatly lowers quality of life, and the treatment response varies from person to person, it has become an important topic in clinical practice. In recent research, there are increasing attempts to understand chronic urticaria not simply as "an itchy rash on the skin," but as one aspect of a "chronic inflammatory state" that is also intertwined with lifestyle factors such as obesity, stress, and sleep problems. This trend has influenced a shift in the goal of treatment from "calming it down for a while" to "long-term control at a level that allows daily life."

Causes

The cause of chronic urticaria is difficult to pin down to a single factor. In actual practice, in more than half of cases, a single clear cause often cannot be identified in the end. Nevertheless, "the situations in which it worsens" are observed relatively often. For example, it may become worse after an infection such as a cold, worsen during extreme stress, or appear in response to physical stimuli such as cold, heat, exercise, pressure, or vibration. Some people also experience worsening after taking certain drugs (especially nonsteroidal anti-inflammatory drugs (NSAIDs)).

An important point is that cases of chronic urticaria explained by "food allergy" alone are less common than one might think. Of course, for some people, certain foods, drugs, or insect stimuli can be clear triggers, but in cases that persist chronically, a situation in which immune signals within the body themselves stimulate the skin's mast cells may be more central than external allergies.

Recent research explains that autoimmune mechanisms may play an important role in some cases of chronic urticaria. That is, antibodies develop not against external substances but against "the body's own proteins or immune receptors," so mast cells are easily activated and continue to release substances such as histamine. In such cases, relapses may recur even if one tries hard to avoid triggers, so the problem is difficult to solve by "avoiding the cause" alone. It is also important that accompanying diseases such as thyroid autoimmune disease (autoimmune thyroiditis) sometimes appear together, so it may not be "a problem of the skin alone."

Genetic Epidemiology

Chronic urticaria differs from a typical hereditary disease that "occurs because of one specific gene." However, some people may have a constitutional tendency in which mast cells are more easily stimulated and inflammatory signals are maintained longer. It has been observed that this tendency may overlap to some degree with family history and with constitutions such as allergic rhinitis or asthma.

To explain genetic epidemiology in a way that is easy for the general public to understand, it is realistic to take it not to mean that "if a family member has a similar itchy skin disease, I will definitely develop it too," but only that a constitution with a sensitive immune response can be shared within a family. In particular, because the cause of chronic urticaria often cannot be reduced to one factor, even if there is a genetic predisposition, whether the disease develops is determined jointly by several factors such as infection, stress, lifestyle habits, and accompanying diseases.

In recent research, there have been active attempts to understand chronic urticaria by dividing it into several groupings of "internal mechanisms." For example, the explanation is that different "endotypes" may exist, such as some patients in whom the immunoglobulin E (IgE) pathway is prominent and others in whom an IgG-based autoimmune type is suspected. Therefore, the most practical message from genetic epidemiology is that even if there is a family history or an allergic constitution, one should not conclude that "the cause must be a food allergy," and that when the condition becomes chronic, other internal mechanisms should also be considered.

General Epidemiology

Hives are so common that almost anyone may experience them at least once in a lifetime. However, chronic urticaria accounts for only a portion of these. Generally, "a state in which hives appear almost daily or repeatedly for 6 weeks or more" is classified as chronic. Chronic urticaria is reported to be more common in women, and there are reports that it is observed relatively more often from middle age onward.

In chronic urticaria, itching can disrupt life even more than the "visible rash." In particular, when itching becomes severe at night, sleep breaks down, fatigue and reduced concentration follow the next day, and anxiety or depression may also accompany it. Recent research repeatedly emphasizes that anxiety, depression, and sleep disorders are relatively common in patients with chronic urticaria, and that the disease itself creates a great psychological burden.

Chronic urticaria may also suddenly become severe and then improve at some point. Some people get better within a year, but in others it can recur for several years. The very fact that "the course is difficult to predict" is a major characteristic of chronic urticaria. Because of these epidemiological characteristics, the goal of treatment is not simply "getting rid of hives once," but reducing relapses and controlling itching in order to restore sleep and daily functioning.

Pathogenesis

To sum up the pathogenesis of chronic urticaria in one sentence, it is "a state in which the skin's mast cells are easily activated and, as a result, the reaction of skin blood vessels leaking and swelling recurs." When mast cells are activated, substances such as histamine are released, and these substances dilate skin blood vessels and increase vascular permeability, so the skin swells (wheals), turns red, and itches.

The important point here is that many cases of chronic urticaria are explained in terms of mast cells being switched on by "internal signals" rather than "external allergens." Recent research emphasizes that the pathway stimulating mast cells is not just one. For example, the proposed scenarios include an IgE-involved pathway, an IgG-involved autoimmune pathway, a scenario in which the complement and coagulation pathways are intertwined, and a scenario in which neuro-immune signals (such as neuropeptides linked to stress) are involved.

In addition, the skin contains not only mast cells; various immune cells such as eosinophils, basophils, and T cells can act together. The cytokines they secrete amplify inflammation and can "prime" the skin into a sensitive state, so that wheals form again even with small stimuli. In summary, it is helpful to understand chronic urticaria not as a problem of the skin surface, but as a state in which the immune network centered on mast cells is "switched on hypersensitively."

Symptoms

The most representative symptoms of chronic urticaria are the repeated appearance of hives (wheals) and the severe itching that accompanies them. In a wheal, the skin swells up locally, the surrounding area turns red, and sometimes the center appears pale. A characteristic feature is that a single lesion usually disappears within 24 hours, and a "migrating pattern," in which new lesions appear at other locations, is common.

The itching goes beyond simple discomfort and can disturb sleep and greatly disrupt daily life. Some people also feel stinging or burning together with it. In addition, dermographism, in which hives rise in a line when the skin is scratched or pressed, may accompany it.

In chronic urticaria, angioedema sometimes appears together. Angioedema is swelling in deeper layers than wheals; the lips, eyelids, hands, or feet may swell, or there may be a feeling of swelling inside the throat. If the throat swells and breathing is difficult, it may be an emergency, so immediate medical care is needed. Recent research explains that in chronic urticaria, symptoms can recur "almost daily" and may persist for several years, and that the unpredictability becomes a great source of stress.

Signs

The representative sign confirmed on examination is a wheal with relatively well-defined borders. Wheals often turn pale when pressed (blanching), vary in size and shape, and may merge to look like large plaques. Above all, the characteristic that "the same lesion usually disappears within 24 hours" is very important.

If a single lesion persists in the same place for more than 24 hours, if pain is more prominent, or if purpura remains like a bruise after it disappears, other diseases such as urticarial vasculitis, rather than simple chronic urticaria, must be differentiated. When angioedema is present, unlike the wheals on the skin surface, a pattern of deep and firm swelling may be seen.

Clues to chronic inducible urticaria (CIndU), which is triggered by physical stimuli, are also sometimes observed. For example, there are patterns such as swelling in a linear shape when the skin is scratched, delayed swelling after pressure, or hives appearing after cold, heat, or exercise. Such signs help more in determining the triggers to be avoided in actual life than in "tests to find the cause."

Screening

In chronic urticaria, "screening" is closer to a process of organizing information so as not to miss warning signs and to reduce unnecessary tests than to a concept with a fixed panel, like large-scale tests to find cancer or infection. The key is taking the medical history and confirming the pattern. First, it is checked whether the hives recur for 6 weeks or more; second, whether a single lesion disappears within 24 hours; third, whether angioedema accompanies them; and fourth, whether there is an association with drugs (NSAIDs, etc.), infection, stress, or physical stimuli.

Next, screening is done for "signs that should raise suspicion of another disease." For example, cases with severe pain or remaining bruises, cases accompanied by systemic symptoms such as fever or weight loss, and cases accompanied by difficulty breathing are difficult to regard as simple chronic urticaria alone.

Basic blood tests (CBC, inflammatory markers (ESR/CRP), thyroid function (TSH), etc.) are considered selectively depending on the patient's situation. However, recent research also mentions that repeating extensive allergy tests to find the cause in chronic urticaria may not always be helpful. That is, "understanding the pattern well and performing the minimum necessary tests in a tailored way" is more realistic than "performing many tests." In addition, recording the degree of wheals and itching over a week, as with the Urticaria Activity Score (UAS7), allows the treatment response to be viewed objectively.

Diagnosis

The diagnosis of chronic urticaria is mostly a clinical diagnosis. That is, the diagnosis can be made by confirming the characteristics that "typical wheals recur, persist for 6 weeks or more, and the lesions usually disappear within 24 hours." If angioedema accompanies this, it is evaluated together as part of the same spectrum.

The most important step in diagnosis is classification. Chronic spontaneous urticaria (CSU) is a type that recurs even without any particular external stimulus, and chronic inducible urticaria (CIndU) is a type triggered in a consistent pattern by stimuli such as pressure, cold, heat, exercise, sweat, or sunlight. The two may also coexist. Tests to identify the cause are chosen "only when needed." If physical triggering is suspected, the pattern can be confirmed through provocation tests such as an ice stimulus or a pressure stimulus.

On the other hand, if lesions persist for more than 24 hours or leave pain or bruising, tests such as a skin biopsy may be needed to consider urticarial vasculitis. The purpose of diagnosis does not end with "giving the condition a name"; it lies in screening out warning signs, organizing triggers, and checking for the possibility of accompanying diseases in order to establish a treatment strategy.

Treatment

The foundation of treatment for chronic urticaria is antihistamines. In particular, regularly taking second-generation H1 antihistamines (sgAH), which cause relatively little drowsiness, is recommended as first-line treatment. If symptoms persist, control is attempted by increasing the dose step by step (usually up to a maximum of 4 times the standard dose). At this stage, taking the medication regularly for a certain period and observing the response is often more helpful than "taking it only when needed."

If the condition is still not controlled, the next step of treatment is needed. Recent research explains that anti-IgE antibody therapy (omalizumab) has become established as second-line treatment, but that a considerable number of patients who do not respond to antihistamines may not achieve complete control even with omalizumab. If control is difficult even after omalizumab, drugs such as the immunosuppressant cyclosporine may be considered, but careful monitoring is needed because of the risk of side effects such as increased blood pressure and decreased kidney function.

Recent research explains that new targeted therapies (e.g., Bruton tyrosine kinase inhibitors (BTK inhibitor) or mast cell-targeted therapies) are under development and that options may increase in the future. A part of treatment that is easy to overlook is lifestyle factors. Because hot showers, drinking alcohol, overwork, lack of sleep, and stress can worsen symptoms, it is good to make a plan to control them alongside drug treatment. An approach of recording one's individual pattern and adjusting accordingly is realistic.

Prognosis

The prognosis of chronic urticaria varies greatly between individuals. Some people improve within a relatively short period and can reduce their medication, while in others it may recur for several years. Recent research emphasizes that when chronic urticaria becomes prolonged, not only the symptoms themselves but also "quality-of-life problems" such as sleep disorders, anxiety and depression, and restrictions on social life may grow.

When estimating the prognosis, the frequency and intensity of the hives, whether angioedema accompanies them, the response to antihistamines, and the possibility of an accompanying autoimmune disease are considered together. For example, in cases that do not respond well to standard treatment, it may take longer to achieve control, and it is more likely that the treatment step will need to be raised.

However, saying "a complete cure is difficult" does not mean "nothing can be done." If treatment goals are clearly set and control is pursued step by step, many patients can maintain their daily lives stably. Recent research also suggests the expectation that, with the emergence of new targeted therapies, faster and more definite control may become possible in some patients. Therefore, it is helpful to understand the prognosis not as a fixed fate, but as something with many factors that can change depending on "which treatment strategy is applied and how consistently."

Prevention

"Complete prevention" of chronic urticaria is not easy. This is because in many cases the cause is unclear and internal immune mechanisms become activated spontaneously. However, there are clearly prevention strategies that reduce relapses and worsening. First, identify triggers and avoid them realistically. If hot environments, sudden changes in body temperature after excessive exercise, tight clothing or sustained pressure, drinking alcohol, or certain drugs (NSAIDs, etc.) are related to the pattern of worsening, include them in the control plan. Second, manage infections and sleep. Some people worsen after a cold or other infections, and lack of sleep tends to intensify itching and stress responses, causing repeated worsening.

Third, because stress can affect actual symptoms through neuro-immune signals rather than "because one is mentally weak," organizing daily routines (sleep, rest, regular exercise, control of caffeine and alcohol) is helpful. Fourth, do not stop medication on your own or change it abruptly. Even when symptoms have subsided, planning "how to taper" together with the medical team is advantageous in reducing relapses.

Recent research emphasizes that chronic urticaria is not simply a problem confined to the skin, but is connected to overall physical and mental health, and that the goal of treatment is "complete control." Prevention, as an extension of this, is most realistically approached as a strategy for maintaining one's whole life without strain.

This content is provided for general medical information only and does not replace individual diagnosis or treatment. If symptoms persist, please consult a medical professional.